GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Diurnal trio dip in after EMA submission in December

Mon, 16th Jan 2017 15:08

(ShareCast News) - A trio of Diurnal Group directors bought shares in the hormone disease specialist, which remain little higher than the low reached late last year.Chairman Peter Allen bought 40,000 shares at 105p and non-executive directors Sam Williams and John Goddard bought 9,248 each at a price of 108p.Diurnal, which floated on AIM in December 2015 market authorisation in late 2017, last month submitted the marketing application to the European Medicines Agency for Infacort, which has the potential to be the first licensed treatment in Europe for Adrenal Insufficiency (AI) specifically designed for use in children under six years of age.This was made on the back of "highly statistically significant" data from clinical trials, with the EMA having already approved a paediatric investigation plan (PIP) for Infacort that set out the regulatory pathway to market authorisation.Diurnal anticipates market authorisation in late 2017, with product revenues expected from early 2018 and the company estimating the total market for paediatric AI and the related condition Congenital Adrenal Hyperplasia in Europe is approximately $28m per year.Top Director BuysDiurnal Group (DNL)Director name: Allen,PeterAmount purchased: 40,000 @ 105.00pValue: £42,000.00Diurnal Group (DNL)Director name: Goddard,JohnAmount purchased: 9,248 @ 108.00pValue: £9,987.84Diurnal Group (DNL)Director name: Williams,SamAmount purchased: 9,248 @ 108.00pValue: £9,987.84Jardine Lloyd Thompson Group (JLT)Director name: Walsh,NicholasAmount purchased: 1,000 @ 997.42pValue: £9,974.25Haydale Graphene Industries (HAYD)Director name: Gibbs,Raymond (Ray) JohnAmount purchased: 4,353 @ 160.00pValue: £6,964.80Fidelity Asian Values (FAS)Director name: Stott,GrahameAmount purchased: 4,000 @ 31.00pValue: £1,240.00Vodafone Group (VOD)Director name: Schellekens,Ronald Amount purchased: 118 @ 212.45pValue: £250.69Sthree (STHR)Director name: Smith,AlexAmount purchased: 65 @ 319.00pValue: £207.35Sthree (STHR)Director name: Elden,GaryAmount purchased: 64 @ 319.00pValue: £204.16Supergroup (SGP)Director name: Sutherland ,EuanAmount purchased: 9 @ 1,712.00pValue: £154.08Supergroup (SGP)Director name: Cartwright,Andrea Amount purchased: 9 @ 1,712.00pValue: £154.08Aviva (AV.)Director name: Amin,NitinbhaiAmount purchased: 31 @ 480.80pValue: £149.05Shoe Zone (SHOE)Director name: Davis ,Nicholas (Nick)Amount purchased: 7,000 @ 1.80pValue: £126.00Top Director SellsRenew Holdings (RNWH)Director name: Samuel,JohnAmount sold: 112,518 @ 434.00pValue: £488,328.14Lindsell Train Inv Trust (LTI)Director name: Landman,RoryAmount sold: 100 @ 86,500.00pValue: £86,500.00
More News
25 Jul 2018 09:39

IP Group Swings To Loss In First-Half On Reduction In Portfolio Gains

LONDON (Alliance News) - IP Group PLC on Wednesday said it saw a swing to loss in the first half of 2018 despite an improvement in its portfolio valuation.The intellectual property-based to

Read more
18 Jun 2018 16:22

Abcam Appoints Former Celltech CFO As Non-Executive Chairman

LONDON (Alliance News) - Life sciences company Abcam PLC said Monday it has appointed the former chief financial officer of Celtech Group PLC as a non-executive chairman.Peter Allen is a at

Read more
3 Apr 2018 16:19

Diurnal To Raise GBP10.5 Million Via Share Placing (ALLISS)

LONDON (Alliance News) - Diurnal Group PLC said on Tuesday that it intends to raise GBP10.5 million through the placing of different types of shares.The

Read more
20 Mar 2018 18:28

Diurnal Nets GBP500,000 From Broker Option Exercise (ALLISS)

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC on Tuesday said that it has received a letter of notice to exercise the broker option in respect of 263,157 in

Read more
12 Mar 2018 13:51

UPDATE: Diurnal Prepares For First Revenue As Appoints Trial Partner

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC on Monday appointed a clinical trial services provider for its Chronocort treatment, as it posted a widened loss

Read more
12 Mar 2018 10:18

Diurnal Interim Loss Widens On Cost Rise As Prepares For First Revenue

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Monday its interim loss widened amid a rise in research and administrative expenses, as it prepares to its

Read more
12 Mar 2018 05:17

UK Stocks-Factors to watch on March 12

March 12 (Reuters) - Britain's FTSE 100 index is seen opening up 8 points higher at 7,233 on Monday, according to financial bookmakers. * GKN-MELROSE: GKN has struck a deal

Read more
25 Jan 2017 09:31

Diurnal Agrees Two Deals With UDG Healthcare Ahead Of Infacort Launch

Read more
17 Jan 2017 15:43

DIRECTOR DEALINGS: Diurnal Non-Executive Ups Interest

Read more
12 Jan 2017 09:04

Diurnal Hires Outgoing Mereo BioPharma Finance Chief Bungay

Read more
20 Dec 2016 12:23

Diurnal Submits European Marketing Application For Infacort

Read more
21 Nov 2016 09:32

Diurnal Doses First Testosterone Replacement Therapy Trial Patients

Read more
5 Oct 2016 15:09

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
11 Jul 2016 08:00

Diurnal and IP Group eye 2017 launch for childhood hormonal treatment

(ShareCast News) - Diurnal Group, 45%-owned by university spin-out specialist IP Group, has produced positive clinical trial results for its treatment for a rare hormonal disease in young children. A European Phase III study for AIM-quoted Diurnal's Infacort treatment for paediatric Adrenal Insuffic

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.